[ad_1]
November 20, 2023
Please see attachment.
Contact information
Investor Relations
Anders Mohr Christensen
+45 2515 2364
[email protected]
Press Relations
Sanne Seyer-Hansen
+45 6038 6207
[email protected]
- 2023_Update on the merger approval process for the combination of Novozymes and Chr. Hansen
[ad_2]
Source link
